$0.6457
0.0285[4.62%]
At close: Apr 16
$0.6457
0[0.00%]
PreMarket: 4:53PM EDT
VolitionRX
(AMEX:VNRX)VolitionRX Stock (AMEX:VNRX), Analyst Ratings, Price Targets, Predictions
VolitionRX Ltd has a consensus price target of $4, established from looking at the 14 latest analyst ratings. The last 3 analyst ratings were released from Cantor Fitzgerald, EF Hutton, and EF Hutton on March 27, 2024, March 27, 2024, and January 2, 2024. With an average price target of $3.83 between Cantor Fitzgerald, EF Hutton, and EF Hutton, there's an implied 521.08% upside for VolitionRX Ltd from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Cantor Fitzgerald
EF Hutton
Cantor Fitzgerald
EF Hutton
EF Hutton
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for VolitionRX
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 03/27/2024 | VNRX | Buy Now | VolitionRX | $0.62 | 305.06% | Cantor Fitzgerald | Ross Osborn | → $2.5 | Reiterates | Overweight → Overweight | Get Alert |
| 03/27/2024 | VNRX | Buy Now | VolitionRX | $0.62 | 629.1% | EF Hutton | Tim Moore | $4.5 → $4.5 | Maintains | Buy | Get Alert |
| 01/02/2024 | VNRX | Buy Now | VolitionRX | $0.62 | 629.1% | EF Hutton | Tim Moore | $4.5 → $4.5 | Reiterates | Buy → Buy | Get Alert |
| 11/21/2023 | VNRX | Buy Now | VolitionRX | $0.62 | 629.1% | EF Hutton | Tim Moore | → $4.5 | Reiterates | Buy → Buy | Get Alert |
| 11/16/2023 | VNRX | Buy Now | VolitionRX | $0.62 | 305.06% | Cantor Fitzgerald | Ross Osborn | $2.1 → $2.5 | Maintains | Overweight | Get Alert |
| 10/30/2023 | VNRX | Buy Now | VolitionRX | $0.62 | 629.1% | EF Hutton | Tim Moore | → $4.5 | Initiates | → Buy | Get Alert |
| 08/16/2023 | VNRX | Buy Now | VolitionRX | $0.62 | 224.04% | Cantor Fitzgerald | Kyle Mikson | $3 → $2 | Maintains | Overweight | Get Alert |
| 06/01/2023 | VNRX | Buy Now | VolitionRX | $0.62 | 872.13% | EF Hutton | Tony Butler | → $6 | Assumes | → Buy | Get Alert |
| 03/16/2023 | VNRX | Buy Now | VolitionRX | $0.62 | 872.13% | EF Hutton | Constantine Davides | → $6 | Reiterates | → Buy | Get Alert |
| 02/01/2023 | VNRX | Buy Now | VolitionRX | $0.62 | — | Benchmark | Bruce Jackson | — | Downgrade | Buy → Hold | Get Alert |
| 12/19/2022 | VNRX | Buy Now | VolitionRX | $0.62 | 872.13% | EF Hutton | Constantine Davides | → $6 | Initiates | → Buy | Get Alert |
| 08/23/2022 | VNRX | Buy Now | VolitionRX | $0.62 | 710.11% | Maxim Group | Jason McCarthy | $8 → $5 | Maintains | Buy | Get Alert |
| 08/15/2022 | VNRX | Buy Now | VolitionRX | $0.62 | 872.13% | Aegis Capital | Nathan Weinstein | $9 → $6 | Maintains | Buy | Get Alert |
| 11/16/2021 | VNRX | Buy Now | VolitionRX | $0.62 | 1358.2% | Aegis Capital | Nathan Weinstein | — | Maintains | Buy | Get Alert |
FAQ
What is the target price for VolitionRX (VNRX)?
The latest price target for VolitionRX (AMEX: VNRX) was reported by Cantor Fitzgerald on March 27, 2024. The analyst firm set a price target for $2.50 expecting VNRX to rise to within 12 months (a possible 287.18% upside). 8 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for VolitionRX (VNRX)?
The latest analyst rating for VolitionRX (AMEX: VNRX) was provided by Cantor Fitzgerald, and VolitionRX reiterated their overweight rating.
When was the last upgrade for VolitionRX (VNRX)?
There is no last upgrade for VolitionRX.
When was the last downgrade for VolitionRX (VNRX)?
The last downgrade for VolitionRX Ltd happened on February 1, 2023 when Benchmark changed their price target from N/A to N/A for VolitionRX Ltd.
When is the next analyst rating going to be posted or updated for VolitionRX (VNRX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of VolitionRX, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for VolitionRX was filed on March 27, 2024 so you should expect the next rating to be made available sometime around March 27, 2025.
Is the Analyst Rating VolitionRX (VNRX) correct?
While ratings are subjective and will change, the latest VolitionRX (VNRX) rating was a reiterated with a price target of $0.00 to $2.50. The current price VolitionRX (VNRX) is trading at is $0.65, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.